Journal of Sleep Disorders: Treatment and CareISSN: 2325-9639

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Commentary, J Sleep Disor Treat Care Vol: 2 Issue: 3

Sodium Oxibate and Breathing

Ortega-Albás JJ1* and Ortega Gabás SP2
1Sleep Unit Universitary, General Hospital of Castellón Castellón de la Plana, Spain
2Polytechnic University of Valencia, Valencia, Spain
Corresponding author :Ortega-Albás JJ
Sleep Unit, Universitary General Hospital of Castellón, Castellón de la Plana, Avenida Capuchinos 41, 2° D. 12004. Castellón, Spain
Tel: 638713784
E-mail: jjoral@ono.com
Received: April 09, 2013 Accepted: August 08, 2013 Published: August 10, 2013
Citation: Ortega-Albás JJ, Ortega Gabás SP (2013) Sodium Oxibate and Breathing. J Sleep Disor: Treat Care 2:3. doi:10.4172/2325-9639.1000116

 

Abstract

Sodium Oxibate and Breathing

The gamma-hydroxybutyrate acid (GHB) is a short chain fatty acid, an endogenous metabolite of gamma–aminobutyric acid (GABA), known major inhibitor neurotransmitter. The GHB presents an action fundamentally at Central Nervous System (CNS) level, and possesses a high affinity for specific receptors located in the cerebral cortex and in the medulla. Sodium Oxybate (SO) is the sodium salt of the GHB. Its character as inhibitor neuromodulator, with the possibility of inducing respiratory depression, and the potential risk of abuse/misuse forces clinicians to be constantly monitoring for signs of misuse.

international publisher, scitechnol, subscription journals, subscription, international, publisher, science

Track Your Manuscript

Awards Nomination

open access